Robotic Surgery - Engineering from a Surgeon's Perspective Speaker/Performer: Susan Lim Sponsor: CITRIS (Ctr for Info Technology Research in the Interest of Society) Abstract: Robotic surgery has made considerable strides in the last 15 years. FDA-appro... By: citrisuc … Continue reading →

Government shutdown won't interrupt congressional mindfulness meditation sessions By JOEL GEHRKE | 10/04/13 03:50 PM Members of Congress and staff who meet for weekly "mindfulness meditation sessions" won't be interrupted by the government shutdown. By VERONIQUE DE RUGY | 10/04/13 02:42 PM Failure to come to an agreement on a continuing resolution has led to the current government shutdown, even as another epic battle looms over another increase in debt ceiling. Unfortunately for taxpayers, whatever... By DAVID M. DRUCKER | 10/04/13 01:51 PM House Republicans announced Friday that they would stand firm on the government shutdown and continue pressing Senate Democrats to negotiate a deal to reopen Washington while approving individual spending bills to fund... By JONATHAN BYDLAK | 10/04/13 01:18 PM Politicians and the public alike have recently focused much attention on efforts in Congress to defund Obamacare, but voter perception about the states role in the process is straight out of Tom Wolfe. Its like... By ASHE SCHOW | 10/04/13 12:52 PM Go here to see the original: FDA blocks innovation in adult-stem-cell research … Continue reading →

Public release date: 3-Oct-2013 [ | E-mail | Share ] Contact: Mary Beth O'Leary moleary@cell.com 617-397-2802 Cell Press The ability to make induced pluripotent stem cells (iPSCs) from mature cells in the body holds great potential for improved drug screening, disease modeling, and medical treatments for numerous conditions. Establishing well-characterized panels of iPSC lines that reflect the diversity of the human population and include samples from patients with a wide range of diseases will be key to tapping into the potential of iPSCs. In the October 3 issue of the Cell Press journal Cell Stem Cell, leading experts in the field publish several opinion pieces on emerging issues related to generating such iPSC banks, and they provide practical recommendations and creative solutions to address challenges associated with such large-scale efforts. Dr. Glyn Stacey of the National Institute for Biological Standards and Control, located in the United Kingdom, and his colleagues recommend approaches for utilizing the knowledge of existing, well-established human embryonic stem cell banks and their experience in standardization to promote quality control in iPSC resource centers. "Not all laboratories will have the same level of expertise in cell culture or familiarity with vital quality control procedures. These will be … Continue reading →

ROCHESTER (WWJ) Members of the Oakland University William Beaumont Institute for Stem Cell and Regenerative Medicine will welcome U.S. Rep. Gary Peters (D-Bloomfield Hills) and Oakland County Executive L. Brooks Patterson to a formal update presentation on progress the institutes research scientists are making in a variety of medical disciplines. The event will take place Friday, Oct. 4 from 5 to 8 p.m. at the Elliott Hall Auditorium on the campus of Oakland University. Both Peters and Patterson will share remarks on how this work promises to positively impact Oakland County and the state of Michigan as a whole. Institute leaders and researchers, colleagues from the Oakland University William Beaumont School of Medicine and Beaumont Health System, academic and administrative leaders from the partner organizations, students, community members and representatives of local media will gather to gain insights on the latest advancements in institute research. More at http://www.oakland.edu/iscrm. Read more: Stem Cell Scientists To Update State, Local Leaders On Research Progress … Continue reading →

Public release date: 3-Oct-2013 [ | E-mail | Share ] Contact: Meghan Weber meghan.weber@childrens.harvard.edu 617-919-3110 Boston Children's Hospital Boston, Mass., Oct. 3, 2013 In a paper in Cell Stem Cell, a team led by researchers in the Boston Children's Hospital's Stem Cell Transplantation Program reports a new approach for turning induced pluripotent stem cells (iPSCs) into hematopoietic stem and progenitor cells for in vivo disease modeling. With this strategywhich they call re-specificationthe team, including Sergei Doulatov, PhD, and George Daley, MD, PhD, of Boston Children's, may have overcome technical barriers to generating blood disease-specific animal models from the thousands of iPSC cell lines now sitting in laboratory freezers around the world. The main advantage of the technique lies in the raw material. The research team started with iPSCs that had already been directed to grow into myeloid progenitors, which are more closely related to the desired blood progenitors than skin or other fully differentiated cell types commonly used in stem cell experiments. The researchers then used a select set of transcription factors to turn back the molecular clock just a little on these committed myeloid cells, turning them into blood progenitors that readily engrafted and differentiated when transplanted into mice. … Continue reading →

Dallas, TX (PRWEB) October 04, 2013 This report is available at a flat 10% Discount on all license types till October 31, 2013. Listed above are original prices and the discount is applicable on the same. Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Categorized by stage of life, several broad categories of stem cells exist, including: Complete report is available @ http://www.rnrmarketresearch.com/opportunities-in-human-embryonic-stem-cell-hesc-products-market-report.html. Embryonic stem cells are stem cells derived from the inner cell mass of a blastocyst, which is a stage reached four to five days post-fertilization. They are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body. Human embryonic stem cells (hESCs) were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first successful culturing of embryonic stem cells from non-human primates occurred at the University of Wisconsin-Madison. Another breakthrough followed at the University of Wisconsin-Madison in November 1998 when a group led by Dr. James Thomson developed a technique to isolate and grow hESCs derived … Continue reading →